摘要:
Provided herein are narrowly distributed multi-armed polyethylene glycol compounds, and hydrogels containing the same. Also provided are methods for treating, adhering, or sealing a biological tissue with hydrogels, and kits for making a hydrogel. Drug releasing compositions also are provided that include a narrowly distributed multi-armed polyethylene glycol compound.
摘要:
To provide a lipid derivative in which a hydrophilic polymer is bound through an acetal linker, and which can accurately control a hydrolysis rate at the pH of the weakly acidic environment in the living body to detach the hydrophilic polymer from a lipid membrane structure. A lipid derivative in which a hydrophilic polymer is bound through a cyclic benzylidene acetal linker represented by formula (1) :
wherein, R 1 and R 6 are each independently a hydrogen atom or a hydrocarbon group; R 2 , R 3 , R 4 and R 5 are each independently an electron-withdrawing or electron-donating substituent or a hydrogen atom; R 7 is a hydrocarbon group having from 8 to 24 carbon atoms, an acyl group having from 8 to 24 carbon atoms, a cholesterol derivative, a glycerolipid, a phospholipid or a sphingolipid; P is a hydrophilic polymer; s is 1 or 2, t is 0 or 1, and s + t is 1 or 2; and Z 1 and Z 2 are each independently a selected divalent spacer.
摘要:
Disclosed is a novel polyoxyalkylene derivative having a functional group which is reactive with various physiologically active substances in accordance with the purposes. This polyoxyalkylene derivative is represented by the general formula (1) below (wherein the symbols are as defined in the description).
摘要:
To provide a hydrophilic polymer derivative having an acetal linker whose hydrolysis rate at pH of a weakly acidic environment in the living body can be accurately controlled, and which does not liberate a low molecular weight substance other than the hydrophilic polymer chain and the drug or the like connected, more specifically, a low molecular weight aldehyde, at the time of hydrolysis. The present invention relates to a hydrophilic polymer derivative having a cyclic benzylidene acetal linker represented by the following formula (1):
wherein R 1 and R 6 are each independently a hydrogen atom or a hydrocarbon group; R 2 , R 3 , R 4 and R 5 are each independently an electron-withdrawing or electron-donating substituent or a hydrogen atom; X 1 is a chemically reactive functional group; P is a hydrophilic polymer; s is 1 or 2, t is 0 or 1, and s + t is 1 or 2; w is an integer of 1 to 8; and Z 1 and Z 2 are each independently a selected divalent spacer.
摘要翻译:为了提供具有缩醛接头的亲水性聚合物衍生物,其能够精确地控制生物体中弱酸性环境的pH的水解速率,并且不释放除了亲水性聚合物链和药物之外的低分子量物质 更具体地说是低分子量的醛。 本发明涉及具有由下式(1)表示的环状亚苄基缩醛连接体的亲水性聚合物衍生物:其中R 1和R 6各自独立地为氢原子或烃基; R 2,R 3,R 4和R 5各自独立地是吸电子或给电子取代基或氢原子; X 1是化学反应性官能团; P是亲水性聚合物; s为1或2,t为0或1,s + t为1或2; w为1〜8的整数, Z 1和Z 2各自独立地为选定的二价间隔基。
摘要:
A modified bio-related substance, wherein at least one poly(alkylene glycol)oxy group represented by the following formula (1) is combined in a molecule: wherein R is a hydrocarbon group having 1 to 24 carbon atoms, OA 1 and OA 2 are each an oxyalkylene group having 2 to 4 carbon atoms, R and OA 2 are the same or different from each other in one molecule, n and m are each average number of moles of the oxyalkylene group added, n represents 0 to 1000, and m represents 10 to 1000.
摘要:
Provided is a method for industrially producing a polyoxyethylene derivative (1) having a plurality of hydroxy groups at a terminal. The method, which is for producing a polyoxyethylene derivative represented by formula (1), comprises steps (A), (B), (C), and (D): step (A) in which a polyhydric alcohol having five or seven hydroxy groups is subjected to a hydroxy-protecting reaction to protect four or six of the hydroxy groups by forming a cyclic benzylidene acetal, thereby obtaining a compound that has a hydroxy group at the 1-position and has a protective group having a cyclic benzylidene acetal structure; step (B) in which ethylene oxide is polymerized with the compound obtained in step (A), in an amount of 11 to 3,650 mol to obtain a polyoxyethylene derivative; step (C) in which the terminal hydroxy group of the polyoxyethylene derivative obtained in step (B) is converted to a functional group reactive with a physiologically active substance; and step (D) in which the protective group of the polyoxyethylene derivative is removed. (In formula (1), L 1 is a divalent linker; X is a functional group reactive with a physiologically active substance; a is 1 or 2; and n is 11-3,650.)
摘要:
To provide a medical polyoxypropylene polymer and a polyoxypropylene/polyoxyethylene block copolymer in which an unsaturated ether content is low and the coloring is suppressed. (A) To a polyoxypropylene polymer which is obtained by ring-opening polymerization of propylene oxide to a starting substance having an active hydrogen reacting with the propylene oxide and contains allyl ether as an impurity is added a tertiary alkoxide of alkali metal in an excess amount based on a molar number of the active hydrogen of the starting substance, followed by heat treating at 115°C or less to isomerize the allyl ether to propenyl ether; and (B) to the mixture obtained in the step (A) is added a mineral acid to adjust pH to 4 or less, followed by treating at 70°C or less to hydrolyze the propenyl ether.
摘要:
A modified biological substance having, per molecule, at least one polyalkylene glycoloxy group represented by the following formula (1): (1) wherein R is a C1-24 hydrocarbon group and OA1 and OA2 each is C2-4 oxyalkylene, provided that R and OA2 in the same molecule are the same or different; and n and m, which indicate the average number of moles of the oxyalkylene added, are 0 to 1,000 and 10 to 1,000, respectively.
摘要:
Provided is a high-molecular-weight polyethylene glycol derivative that does not cause vacuolation of cells. A degradable polyethylene glycol derivative represented by the following formula (1):
wherein m is 1 - 7, n1 and n2 are each independently 45 - 682, p is 1 - 4, R is an alkyl group having 1 - 4 carbon atoms, Z is an oligopeptide with 2 - 8 residues composed of neutral amino acids excluding cysteine, Q is a residue of a compound having 2 - 5 active hydrogens, X is a functional group capable of reacting with a bio-related substance, and L 1 , L 2 , L 3 , L 4 and L 5 are each independently a single bond or a divalent spacer.